Resources

Machine Learning Identifies Histologic Features Associated With Regression of Cirrhosis in Treatment for Chronic Hepatitis B

July 27, 2025

PathAI and Novo Nordisk present AI-powered scoring showing significant reduction of fibrosis following semaglutide treatment inpatients with NASH

July 27, 2025

PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis ("AIM-MASH") on the AISight Image Management System

July 27, 2025

Machine-Learning-Quantified Lupus Nephritis Histological Features Correlate with NIH Activity and Chronicity Index Subscores

July 27, 2025

Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association

July 27, 2025

PathAI and ConcertAI Partner to Create First-in-Class Histopathology and Clinical Real-World Data Solutions

July 27, 2025

PathAI Machine Learning Models Reveal Treatment-Induced Changes in the Non-Small Cell Lung Cancer Tumor Microenvironment in Samples from the LCMC3 Study

July 27, 2025

Quantitative multimodal anisotropy imaging enables automated fibrosis assessment of H&E-stained tissue

July 27, 2025

Machine learning-based characterization of the breast cancer tumor microenvironment for assessment of neoadjuvant-treatment response

July 27, 2025

PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the American Association for the Study of Liver Diseases (AASLD) 2022 Liver Meeting

July 27, 2025

Self-training of Machine Learning Models for Liver Histopathology: Generalization under Clinical Shifts

July 27, 2025

PathAI Announces Launch of AIM-TumorCellularity (AIM-TC) to Inform Advanced Molecular Testing

July 27, 2025

PathAI’s Latest Release! Explore AISight Version 2.10!

July 27, 2025

PathAI and Gilead Report Data from Machine Learning Model Predictions of Liver Disease Progression and Treatment Response at AASLD’s The Liver Meeting 2020

July 27, 2025

Machine learning based identification of predictive features of the tumor microenvironment and vasculature in NSCLC patients using the IMpower150 study

July 27, 2025

Introducing PathAI's ContriMix: Content and Attribute Mixing for Domain Generalization

July 27, 2025

PathAI to Present on AI-based Models to Advance Tumor Analysis and Oncology Drug Development at American Association for Cancer Research Annual Meeting 2023

July 27, 2025

AI Products | IBD Information Sheet

July 27, 2025

Digital pathology and artificial intelligence in translational medicine and clinical practice

July 27, 2025

PathAI To Present Three Abstracts at International Liver Congress 2022

July 27, 2025

Concordance analysis of AI-powered CD8 quantification and automated CD8 topology with manual histopathological assessment across seven solid tumor types

July 27, 2025

PathAI to Present on AI Models Supporting Advances in Oncology Research at Society for Immunotherapy of Cancer Annual Meeting

July 27, 2025

CD8+ T Cells in Tumor Parenchyma and Stroma by Image Analysis and Gene Expression Profiling: Potential Biomarkers for Immuno-oncology Therapy

July 27, 2025

Variability in Liver Biopsy Assessment: Data from the Pegozafermin Phase 1b/2a Study in Subjects with Non-Alcoholic Steatohepatitis (NASH)

July 27, 2025

Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab

July 27, 2025

PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development

July 27, 2025

PathAI Announces Poster Presentations at the 2025 American Association of Cancer Research Annual Meeting

July 27, 2025

PathAI and Genentech Present on AI-Powered Pathologic Response Assessment in NSCLC at the American Society of Clinical Oncology Virtual Scientific Program 2021

July 27, 2025

Expanding into Digital Diagnostics: Letter from Andy Beck, MD, PhD - Co-Founder and CEO of PathAI

July 27, 2025

Webinar

Webinar: Introduction to the AIM-HER2 Breast Cancer Algorithm

July 27, 2025

Steatosis reduction assessed by MRI-PDFF was consistent with ML evaluation in patients with NASH cirrhosis

July 27, 2025

Machine Learning Models can Quantify CD8 positivity in Melanoma Clinical Trial Samples

July 27, 2025

PathAI and Labcorp Broaden Strategic Collaboration to Accelerate Use of AI-Powered Pathology

July 27, 2025

PathExplore™ Information Sheet

July 27, 2025

PathAI Announces Strategic Investment from Merck Global Health Innovation Fund and Bristol-Myers Squibb to complete $75M Series B Funding

July 27, 2025

AI-powered analysis of nuclear morphology associated with prognosis in high-grade serous carcinoma

July 27, 2025

Machine learning-enabled continuous scoring of histologic features facilitates prediction of clinical disease progression in patients with non-alcoholic steatohepatitis

July 27, 2025

Video

Introducing PathExplore

July 27, 2025

Podcast

Vital Signs Podcast | The Future of AI in Medical Diagnosis feat. Dr. Andy Beck

July 27, 2025

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

July 27, 2025

PathAI Announces New Executive Appointment to Drive Commercial Growth of Biopharma Partnerships, Lab Capabilities, and Clinical Innovation

July 27, 2025

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis

July 27, 2025

PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials

July 27, 2025

PathAI Announces Launch of ArtifactDetect Model on AISight, Pioneering Automated Slide Quality Analysis in Pathology Labs

July 27, 2025

Multi stain graph fusion for multimodal integration in pathology

July 27, 2025

Development of a high-throughput image processing pipeline for multiplex immunofluorescence whole slide images at scale

July 27, 2025

Machine Learning Models Identify Key Histological Features of Renal Cell Carcinoma Subtypes

July 27, 2025

PathAI's AISight Dx Image Management System is CE Marked for Primary Diagnosis

July 27, 2025

PathAI Launches AIM-IHC Breast Panel on AISight® Platform to Streamline Breast Cancer Biomarker Quantification and Improve Pathologist Efficiency

July 27, 2025

PathAI’s AISight Just Got Even Better! Discover AISight Version 2.9

July 27, 2025

PathAI Announces Strategic Investment from LabCorp

July 27, 2025

Characteristics of the tumor microenvironment in IDH1-mutated cholangiocarcinoma patients from ClarIDHy trial

July 27, 2025

Foundation Models Technology Information Sheet

July 27, 2025

PathAI Grabs $11M to Build A.I. Tools for Pathology

July 27, 2025

AI-based quantitation of cancer cell and fibroblast nuclear morphology reflects transcriptomic heterogeneity and correlates with survival in breast cancer

July 27, 2025

PathAI Showcases AI-Powered Pathology Innovations at the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting

July 27, 2025

PathAI Unveils New Features on AISight® Image Management System: Introducing Guided Algorithm Review and Z-Stack Image Support

July 27, 2025

AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials

July 27, 2025

PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb

July 27, 2025

Behind the scenes: Dr. Andy Beck, PathAI CEO, talks PathExplore

July 27, 2025

AI Products | Oncology Information Sheet

July 27, 2025

Identification of clinically relevant spatial phenotypes in large-scale multiplex immunofluorescence data via unsupervised graph learning in non-small cell lung cancer

July 27, 2025

PathAI Announces Research Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

July 27, 2025

PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI

July 27, 2025

PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics

July 27, 2025

PathAI Announces Research Presentations at the San Antonio Breast Cancer Symposium

July 27, 2025

A multi-tumor machine learning model to identify tertiary lymphoid structures (TLS) in histopathological H&E images as a potential clinical biomarker

July 27, 2025

Concordance analysis of AI-powered CD8 quantification and automated CD8 topology with manual histopathological assessment across seven solid tumor types

July 27, 2025

The utility of AI-powered spatial classification of intratumoral CD8+ immune-cell topology in predicting overall survival in patients with melanoma as part of the CheckMate 067 clinical trial

July 27, 2025

PathAI Announces Research Presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting

July 27, 2025

A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis

July 27, 2025

PathAI launches six additional oncology indications for PathExplore, an AI-powered pathology panel for spatial analysis of the tumor mircroenvironment

July 27, 2025

PathAI Earns ISO 27001 Security Certification

July 27, 2025

Exploratory analyses of NASH histology using CRN scores derived from a multi-stain machine learning method

July 27, 2025

An Empirical Framework for Validating Artificial Intelligence–Derived PD-L1 Positivity Predictions Applied to Urothelial Carcinoma

July 27, 2025

Machine Learning Analysis of H&E Lung Adenocarcinoma Tumor Microenvironment Shows Association of Human Interpretable Histopathological Features with KEAP1 Mutations

July 27, 2025

PathAI Receives FDA Clearance for AISight® Dx Platform for Primary Diagnosis

July 27, 2025

A Deep Learning Approach to Analysis of MRCP Images Predicts Clinical Events and Progression to Cirrhosis in Patients With Primary Sclerosing Cholangitis

July 27, 2025

Dissecting the Business Case for Adoption and Implementation of Digital Pathology: A White Paper from the Digital Pathology Association

July 27, 2025

Variability in Liver Biopsy Assessment: Data from the Pegozafermin Phase 1b/2a Study in Subjects with Non-Alcoholic Steatohepatitis (NASH)

July 27, 2025

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

July 27, 2025

Machine Learning Models Accurately Interpret Liver Histology and Are Associated With Disease Progression in Patients With Primary Sclerosing Cholangitis

July 27, 2025

Precision for Medicine and PathAI Announce Strategic Collaboration to Advance AI-Powered Clinical Trial Services and Biospecimen Products

July 27, 2025

Validation of a Machine Learning-Based Approach (DELTA Liver Fibrosis Score) for the Assessment of Histologic Response in Patients with Advanced Fibrosis due to NASH

July 27, 2025

Comparison of the effects of semaglutide on liver histology in patients with non-alcoholic steatohepatitis cirrhosis between machine learning model assessment and pathologist evaluation

July 27, 2025

Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis

July 27, 2025

The Boston Globe Names Andy Beck to Tech Power Players 50

July 27, 2025

Digital Pathology Uncovers Multi-Omic Hallmarks of Lung Cancer in Histopathology Images

July 27, 2025

PathAI & Gilead Present Research at ILC 2020 Demonstrating AI Models Accurately and Reproducibly Assess Treatment Response and Disease Progression across Liver Disorders

July 27, 2025

PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions

July 27, 2025

PathAI presents results at The AASLD Liver Meeting 2021 showing that panel scoring of NASH histological features can reduce bias and increase reproducibility

July 27, 2025

Artificial intelligence–powered immune phenotyping of advanced or metastatic urothelial carcinoma clinical trial samples from hematoxylin and eosin–stained whole slide images

July 27, 2025

Integration of Machine Learning-Based Histopathology and Hepatic Transcriptomic Data Identifies Genes Associated With Portal Inflammation and Ductular Proliferation as Predictors of Disease Progressio

July 27, 2025

PathAI Launches AIM-HER2 Breast Cancer, an Artificial Intelligence-Powered HER2 Scoring Algorithm for Biopharma Research and Clinical Labs

July 27, 2025

PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy

July 27, 2025

A Machine Learning Model Based on Liver Histology Predicts the Hepatic Venous Pressure Gradient in Patients With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

July 27, 2025

PathAI Announces Collaboration with Akoya Biosciences to Offer a Spatial Biology and AI-Powered Analysis Solution

July 27, 2025

The Future of Pathology: How Labs Will Benefit from Adopting a Digital and AI Strategy

July 27, 2025

ContriMix: Unsupervised disentanglement of content and attribute for domain generalization in microscopy image analysis

July 27, 2025

Machine Learning Based Quantification of Histology Features from Patients Treated for Chronic Hepatitis B Identifies Features Associated with Viral DNA Suppression and HBeAg Loss

July 27, 2025

PathAI Commences New Year with Strong Foundation Following Key 2023 Achievements

July 27, 2025

Dr. Eric Walk Joins PathAI as Chief Medical Officer

July 27, 2025

PathAI Announces Research Presentations at the Society for Immunotherapy of Cancer's 38th Annual Meeting

July 27, 2025

PathAI Welcomes Mary Padilla, M.D., to Lead Clinical Development Services for Biopharma

July 27, 2025

Artificial intelligence–powered immune phenotyping of advanced or metastatic urothelial carcinoma clinical trial samples from hematoxylin and eosin–stained whole slide images

July 27, 2025

PathAI Announces Commercial Availability of AISight™ Digital Pathology Image Management System to Power the Next Generation of Pathology Labs

July 27, 2025

PathAI Announces IBD Explore, an AI-powered Histopathology Panel to Unlock Insights for Ulcerative Colitis from the Inflammatory Microenvironment

July 27, 2025

PathAI Receives Both FDA 510(k) Clearance and CE Mark for AISight Dx Platform

July 27, 2025

From Pixels to Precision 004: Benefits of Artificial Intelligence

July 27, 2025

Artificial Intelligence powered predictive analysis of atypical ductal hyperplasia from digitized pathology images

July 27, 2025

Quantitative analysis of fiber-level collagen features in H&E whole-slide images predicts neoadjuvant therapy response in patients with HER2+ BC

July 27, 2025

PathAI to present AI-powered research insights at the European Association for the Study of the Liver Congress 2024

July 27, 2025

Machine Learning Models Identify Novel Histologic Features Predictive of Clinical Disease Progression in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

July 27, 2025

PathAI to Present at Digestive Disease Week

July 27, 2025

Podcast

This Week in Startups Podcast | Next Unicorns: Bringing AI to pathology with PathAI CEO Andy Beck

July 27, 2025

Minimizing Variability and Increasing Concordance for NASH Histological Scoring in NASH Clinical Trials

July 27, 2025

Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis

July 27, 2025

Artificial Intelligence–Powered and Manual Assessment of PD-L1 Are Comparable in Predicting Response to Neoadjuvant Atezolizumab in Patients With Resectable Non-Squamous, Non-Small Cell Lung Cancer

July 27, 2025

Application of an interpretable graph neural network to predict gene expression signatures associated with tertiary lymphoid structures in histopathological images

July 27, 2025

PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions

July 27, 2025

Deep-Learning–Based Prediction of c-MET Status From Digitized H&E-Stained Non-small Cell Lung Cancer Tissue Samples

July 27, 2025

From Pixels to Precision 005: The Role of Digital Pathology in Addressing Pathology Workforce Challenges

July 27, 2025

PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services

July 27, 2025

PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

July 27, 2025

Machine Learning Analysis of H&E Lung Adenocarcinoma Tumor Microenvironment Shows Association of Human Interpretable Histopathological Features with KEAP1 Mutations

July 27, 2025

Artificial intelligence (AI)-based classification of stromal subtypes reveals associations between stromal composition and prognosis in NSCLC

July 27, 2025

Characteristics of the tumor microenvironment in IDH1-mutated cholangiocarcinoma patients from ClarIDHy trial

July 27, 2025

Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis due to NASH

July 27, 2025

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

July 27, 2025

Machine-Learning-Quantified Lupus Nephritis Histological Features Correlate with NIH Activity and Chronicity Index Subscores

July 27, 2025

PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners

July 27, 2025

Video

Quantification of Digital Pathology-based Immune Phenotyping Reveal Biomarkers for Therapy Selection in NSCLC

July 27, 2025

MASH and LiverExplore™ Information Sheet

July 27, 2025

PathAI Launches AISight Link to Support integration Solutions for Laboratory Customers and Biopharma Partners

July 27, 2025

Cell-type-specific nuclear morphology predicts genomic instability and prognosis in multiple cancer types

July 27, 2025

Generation of an atlas characterizing the tumor immune microenvironment via AI-based histologic mapping of multiple cancer types at scale

July 27, 2025

Fully automated histological classification of cell types and tissue regions of celiac disease is feasible and correlates with the Marsh score

July 27, 2025

PathAI demonstrates the potential of AI-based Characterization of the Tumor Microenvironment at ASCO

July 27, 2025

Retrospective AI-based Measurement of NASH Histology (AIM-NASH) Analysis of Biopsies From Phase 2 Study of Resmetirom Confirms Significant Treatment-induced Changes in Histologic Features of Nonalcoho

July 27, 2025

AIM PD-L1-NSCLC: Artificial intelligence-powered PD-L1 quantification for accurate prediction of tumor proportion score in diverse, multi-stain clinical tissue samples

July 27, 2025

Artificial Intelligence Enables Quantitative Assessment of Ulcerative Colitis Histology

July 27, 2025

PathAI Composite PD-L1 and AI-powered CD8+ Topology Biomarker May Improve Prediction of Immuno-Oncology Treatment Response in Patients with Melanoma at the Society for Immunotherapy of Cancer Meeting

July 27, 2025

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration

July 27, 2025

PathAI Announces Strategic Investment from Merck Global Health Innovation Fund and Bristol-Myers Squibb to complete $75M Series B Funding

July 27, 2025

From Pixels to Precision 002: Making Sense of the Digital Pathology Ecosystem- Part 2

July 27, 2025

Steatosis reduction assessed by MRI-PDFF was consistent with ML evaluation in patients with NASH cirrhosis

July 27, 2025

PathAI and Bristol Myers Squibb find Positive Association of Digital PD-L1 Expression with Outcomes in nivolumab-treated Patients in an Exploratory analysis

July 27, 2025

Clinical Development Services Information Sheet

July 27, 2025

Liver Biopsy Graph Neural Networks for Automated Histologic Scoring using the NASH CRN System

July 27, 2025

PathAI ML Models Based on Human Interpretable Features Predict Clinically-Relevant Molecular Phenotypes Across Cancers

July 27, 2025

Quantum Pathology Enhances Digital Pathology Capabilities with the Adoption of PathAI's AISight Image Management System

July 27, 2025

PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics

July 27, 2025

AI Offerings Information Sheet

July 27, 2025

AI-powered segmentation and analysis of nuclear morphology predicts genomic and clinical biomarkers in multiple cancer types

July 27, 2025

AI-powered analysis of nuclear morphology associated with prognosis in high-grade serous carcinoma

July 27, 2025

Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes

July 27, 2025

PathAI Appoints Brandon Eldredge as Chief Financial Officer

July 27, 2025

PathAI Appoints Elizabeth Storti as Chief People Officer

July 27, 2025

PathAI Welcomes Two New Executives as it Strengthens its Biopharma Business Leadership Team

July 27, 2025

Quantitative analysis of fiber-level collagen features in H&E whole-slide images predicts neoadjuvant therapy response in patients with HER2+ BC

July 27, 2025

PathAI Announces Research Presentations at the 2024 AACR Annual Meeting

July 27, 2025

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma

July 27, 2025

Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH

July 27, 2025

From Pixels to Precision 003: Benefits of Digital Pathology

July 27, 2025

PathAI Announces Early Access Program to Drive Adoption of AISight Image Management System in Anatomic Pathology Laboratories Across Mainland Europe

July 27, 2025

PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

July 27, 2025

Improved statistical benchmarking of digital pathology models using pairwise frames evaluation

July 27, 2025

NASH therapies head toward landmark approval

July 27, 2025

PathAI Launches PathExplore™ Fibrosis: An AI-Powered Pathology Breakthrough in Fibrosis, Collagen, and Fiber Quantification Directly from Whole Slide Images

July 27, 2025

Validation of Digital Pathology Platform for Metabolic-Associated Steatohepatitis for Clinical Trials

July 27, 2025

Video

PathAI on Nightly Business News

July 27, 2025

PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024

July 27, 2025

PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial

July 27, 2025

Rethinking Machine Learning Model Evaluation in Pathology

July 27, 2025

VIZIA Diagnostics Selects PathAI and the AISight Image Management System to Support the Transition to Digital and AI-Powered Pathology

July 27, 2025

From Pixels to Precision 001: Making Sense of the Digital Pathology Ecosystem- Part 1

July 27, 2025

PathAI MASH Algorithms on navify® Digital Pathology

July 27, 2025

PathAI Ranked 420th Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

July 27, 2025

Machine learning model PD-L1 22C3 scoring of a multi-scanner, real-world reference laboratory NSCLC dataset generates scores comparable with manual pathologist scoring

July 27, 2025

PathAI Launches Precision Pathology Network to Advance AI-Powered Pathology

July 8, 2025

PathAI and Rede D’Or Announce Strategic Partnership to Bring AI-Powered Pathology Solutions to Brazil

February 11, 2025

PathAI Recognized for the “Diagnostics Innovation of the Year” By BioTech Breakthrough

November 25, 2024

Real-World Data Information Sheet

October 11, 2024

PathAI Chief Medical Officer Eric Walk Named to PharmaVoice 100 List

October 11, 2024

PathExplore™ IOP Information Sheet

October 11, 2024

IHC Explore™ Information Sheet

October 11, 2024

PathAI Announces Collaboration with the Crohn’s & Colitis Foundation to Advance Novel IBD Research and Development

October 3, 2024

PathAI Collaborates with GoldPath to Elevate Digital Pathology Capabilities with AISight Image Management System

September 3, 2024

Real-World Data and Real-World Impact

August 30, 2024

RWD with ConcertAI

August 1, 2024

RWD with Aster Insights

August 1, 2024

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

July 11, 2024

Analytical and Clinical Validation of AIM-NASH, a Digital Pathology Tool for Artificial Intelligence-based Measurement of Nonalcoholic Steatohepatitis Histology

May 29, 2024

PathAI announces PLUTO: a state-of-the-art Foundation Model to enhance AI-powered pathology tools

May 14, 2024

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

May 1, 2024

Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology

April 25, 2024

Classification of the Tumor Immune Microenvironment Using Machine-Learning-Based CD8 Immunophenotyping As a Potential Biomarker for Immunotherapy and TGF-β Blockade in Nonsmall Cell Lung Cancer

April 18, 2024

PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology

April 16, 2024

Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments

April 4, 2024